Investor
Peloton anticipates treadmill recalls will cost the company roughly $165 million.
Based on the results of ZOE’s at-home gut health, blood sugar and blood fat tests, the company creates a personalized dietary plan for its users.
The company hopes to equip China’s hospitals with digital surgery solutions to enable better health outcomes.
The round was led by the Chernin Group and Elysian Park.
General Atlantic, Centene and AXA Venture Partners led the Series D round.
This latest infusion of cash values Collective Health at $1.5 billion.
Coming in six months after its $26 million Series A round, Headway now boasts $103 million in total funding and a new valuation of $750 million.
Alife also added Deena Shakir, a partner at Lux Capital, to its board of directors.
PeriGen will continue its focus on a perinatal clinical decision support tool.
As of Friday afternoon, Dexcom’s stock has fallen 6.3% from about $422 to $395.